Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by Skrit37on Sep 10, 2020 9:30am
122 Views
Post# 31532338

RE:RE:RE:RE:RE:Coming faster than expected

RE:RE:RE:RE:RE:Coming faster than expected
Skrit37 wrote:
Onenessofall121 wrote:
cactuseskimo wrote: This worries me some though. Apparently the type of screening test we have in Aristotle and the accuracy it has, is pretty much considered the Holy Grail of cancer tests. Yet, in this article which describes a similar test but with much less accuracy, there is already a lot of hype and hoopla surrounding it. Furthermore, the article goes on to mention the main competitors in the cancer screening space, and not one mention of SZLS - yet we are the ones who apparently have the golden egg ready to hatch in just a few months.  Are we that unknown? What's up with that?

I'm not letting this one go . Why is it that nobody knows about us in the industry ? I want an answer here .


I think its very easy to answer as i see it...the companies that are mensioned have millllllllions of dollars ivested behind them to get the word out....we do not...money that we have been able to produce has kept the lights on and invested back into the technology and the infrustructure to roll it out when it ready... fortunatly covid has helped bring in unexpected cash and is helping accelerate this.....once the word spreads and money becomes available to get the word out quicker.....this will blow up quick ...or get bought out buy one of these competators


Bullboard Posts